According to recent reports from Australian media outlet Miragenews, the Australian Medical Association (AMA) has been advocating for stronger measures to combat non-therapeutic e-cigarettes for many years. The AMA has expressed its support for the passing of legislation aimed at bolstering tobacco and e-cigarette regulation.
In 2023, the Public Health (Tobacco and Other Products) Act will consolidate eight different tobacco laws, regulations, and voluntary agreements to streamline enforcement.
At the same time, new measures have been introduced to help Australia achieve greater success in the battle against tobacco and nicotine addiction. These laws also apply to e-cigarettes, which are increasingly becoming a gateway to smoking for many young Australians. The inclusion of new reports and information requirements also extends to the impact on the tobacco industry, aiming to provide urgent transparency and influence policy.
AMA, in collaboration with the Australian government, the opposition, and cross-party cooperation, has worked diligently to ensure that the bill, after undergoing four revisions, is not weakened and has made it clear to all participants that the implementation of the bill should not be delayed.
Earlier this month, Dr Michael Bonning, the President of the Australian Medical Association (AMA) in New South Wales, attended a Senate inquiry, expressing his support for the legislation and stating that "despite significant progress in tobacco control in Australia over the past few decades, tobacco use remains a leading cause of preventable death and disability.
The AMA concluded by stating that it will continue to collaborate with the minister to undertake broader e-cigarette reforms. It is reported that this reform will commence on January 1, 2024, banning the import of disposable e-cigarettes.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
